[1] Sérée O, Altieri M, Guillaume E, et al. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients. Liver Transpl. 2018. 24(10): 1425-1436.
[2] Miyazaki T, Sato S, Kondo T, et al. National survey of de novo malignancy after solid organ transplantation in Japan. Surg Today. 2018. 48(6): 618-624.
[3] Zhang Zhijun,Zhong Haigang,Zhang Wei. De novo digestive system malignancy after liver transplantation. Chinese Journal of Organ Transplantation. 2016. 37(9): 513-517.
[4] Lee HS, Yoo DJ, Park HW, et al. Is a stricter colonoscopy screening protocol necessary in liver transplant recipients? Comparison with an average-risk population. Dis Colon Rectum. 2014. 57(8): 976-82.
[5] Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF, Engels EA. Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant. 2016. 16(3): 960-7.
[6] Atassi T, Thuluvath PJ. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. J Clin Gastroenterol. 2003. 37(1): 72-3.
[7] Chen W, Zheng R, Zuo T, Zeng H, Zhang S, He J. National cancer incidence and mortality in China, 2012. Chin J Cancer Res. 2016. 28(1): 1-11.
[8] Rao Wei, Xie Man, Liu Dongyue, et al. Analysis of de novo malignancies after liver transplantation in China: based on literature published. Chinese Journal of Transplantation(Electronic Version). 2018. 12(4): 165-169..
[9] Gschwantler M, Kriwanek S, Langner E, et al. High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol. 2002. 14(2): 183-8.
[10] Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000. 47(2): 251-5.
[11] Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986. 27(1): 117-26.
[12] Holme Ø, de Lange T, Stallemo A, et al. Routine vs. on-demand analgesia in colonoscopy: a randomized clinical trial. Endoscopy. 2016. 48(9): 823-8.
[13] Zhang K, Yuan Q, Zhu S, Xu D, An Z. Is Unsedated Colonoscopy Gaining Ground Over Sedated Colonoscopy. J Natl Med Assoc. 2018. 110(2): 143-148.
[14] Aljebreen AM, Almadi MA, Leung FW. Sedated vs unsedated colonoscopy: a prospective study. World J Gastroenterol. 2014. 20(17): 5113-8.
[15] Holme O, Bretthauer M, de Lange T, et al. Risk stratification to predict pain during unsedated colonoscopy: results of a multicenter cohort study. Endoscopy. 2013. 45(9): 691-6.
[16] Kim WH, Cho YJ, Park JY, Min PK, Kang JK, Park IS. Factors affecting insertion time and patient discomfort during colonoscopy. Gastrointest Endosc. 2000. 52(5): 600-5.
[17] LAI Xueying,TANG Xiaowei,HUANG Silin. Risk factors of pain during colonoscopic examination. Journal of Southern Medical University. 2017. 37(4): 482-487.
[18] D'Arcy ME, Coghill AE, Lynch CF, et al. Survival after a cancer diagnosis among solid organ transplant recipients in the United States. Cancer. 2019. 125(6): 933-942.
[19] Jeschek P, Ferlitsch A, Salzl P, et al. A greater proportion of liver transplant candidates have colorectal neoplasia than in the healthy screening population. Clin Gastroenterol Hepatol. 2015. 13(5): 956-62.
[20] Weismüller TJ, Bleich F, Negm AA, et al. Screening colonoscopy in liver transplant candidates: risks and findings. Clin Transplant. 2013. 27(2): E161-8.
[21] Oey RC, van Tilburg L, Erler NS, et al. The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation. Hepatology. 2019 .
[22] Kang EA, Koh SJ, Kim JW, et al. Prevalence of advanced colorectal neoplasm is higher in liver transplant recipients. Turk J Gastroenterol. 2018. 29(3): 316-324.
[23] Ma AT, Therrien A, Giard JM, von RD, Bouin M. Alcoholic liver disease is a strong predictor of colorectal polyps in liver transplant recipients. Endosc Int Open. 2017. 5(9): E918-E923.